Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer-Reference-Cited by-同舟云学术

Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer

Published:2020-04-03 Issue:2 Volume:10 Page:413-428
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Zeissler Marie-Louise¹,Li Vivien²³⁴,Parmar Mahesh K.B.⁴,Carroll Camille Buchholz¹

Affiliation:

1. Applied Parkinson’s Research Group, University of Plymouth, Faculty of Health: Medicine, Dentistry and Human Sciences, Plymouth, United Kingdom

2. Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK

3. Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Queen Square, London, United Kingdom

4. MRC Clinical Trials Unit at UCL, University College London, London, United Kingdom

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference97 articles.

1. Short- and long-term cost and utilization of health care resources in Parkinson’s disease in the UK;Weir;Mov Disord,2018

2. Projection of the prevalence of Parkinson’s disease in coming decades: Revisited HHS Public Access;Rossi;Mov Disord,2018

3. Bioinformatics in translational drug discovery;Wooller;Biosci Rep,2017

4. Progress in biopharmaceutical development;Kesik-Brodacka;Biotechnol Appl Biochem,2018

5. Molecular dynamics simulation for all;Hollingsworth;Neuron,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease;Movement Disorders;2024-06-26

2. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative;Journal of Parkinson's Disease;2024-06-04

3. Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol;BMJ Open;2023-12

4. Exercise Made Accessible: the Merits of Community-Based Programs for Persons with Parkinson’s Disease;Current Neurology and Neuroscience Reports;2023-10-04

5. Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop;Neurotherapeutics;2023-10